Case Study submissions should focus on the use of HEOR to inform a healthcare decision or series of decisions, noting successes and lessons learned. The scope of case studies may range from local (for example, from a local healthcare payer or provider organization serving a small jurisdiction or region) to national (for example, from a regulator or HTA body serving a country). Case studies should be presented from a clearly stated stakeholder perspective(s) such as payer, patient, provider, industry, or government (including government-affiliated or government-commissioned organizations). Academic entities whose research informs healthcare decisions are also encouraged to submit their work.
An important distinction between Case Studies and Research submission categories is that Case Studies employ the following format and may include qualitative descriptions of experiences without necessarily involving formal research design or execution.
- Submissions should entail use of HEOR at the population or group level (or consideration of its use).
- We encourage submissions that involve the use (or consideration of the use) of real-world data.
- Clinical case studies which present the course of care or outcomes for an individual patient are outside the scope of interest.
- Business case studies which refer to a named product or are promotional in nature will not be considered.
- Abstracts that have been submitted to another conference and copyright has been transferred to another organization will not be considered.
- Case study abstracts presented at a previous ISPOR meeting are not allowed.
- Accepted case studies will be slated as either an oral or a poster presentation. For oral presentations, the total case study presentation time will be 15-20 minutes, depending on the number of presenters. Accepted case studies may be grouped with 2 or more abstracts in a session.
- Example of a case study abstract submission is available here.
- Length of Abstract: 300 words
ISPOR is strongly committed to diversity. The Society’s Strategic Plan and core values embrace excellence through encouragement and acceptance of diverse ideas, cultures, and disciplines. Case study submissions are encouraged from all stakeholders and are evaluated based on merit. ISPOR also aims to reflect the diversity of its membership in all endeavors and encourages consideration of diversity in abstract submissions. Diversity dimensions include (but not limited to) gender, career stage, ethnicity, race, education, sexual orientation, region/geographic location, physical disability, and religion. Additional information can be found at the Society’s Diversity Policy.
Below are instructions to assist with your case study abstract submission. If you have any questions concerning the research submission process, please contact email@example.com.
STEP 1: TITLE
When submitting your abstract, titles must be submitted in title case. Titles have a 225 maximum character limit. Your title should succinctly state the topic of the work.
STEP 2 & 3: MAIN TOPIC/TAXONOMY AND SUBTOPICS FOR RESEARCH SUBMISSIONS
When submitting your abstract, you must select at least one topic and subtopic that best describes your abstract. This topic/taxonomy will also be used to assign the appropriate peer reviewer to your submission.
After selecting your main topic/taxonomy, you may then choose up to four subtopics. Expand each taxonomy area below to view the available subcategories. If these subtopic areas do not apply to your research, select “Does Not Apply” at the bottom of the “Subtopics” page.
Comparative Effectiveness or Efficacy
Clinician Reported Outcomes
Clinician Outcomes Assessment
Relating Intermediate to Long-term Outcomes
Cost/Cost of Illness/Resource Use Studies
Budget Impact Analysis
Thresholds & Opportunity Cost
Trial-based economic evaluation
Work & Home Productivity - Indirect Costs
Value of Information
Novel & Social Elements of Value
Safety & Pharmacoepidemiology
Prevalence, Incidence, & Disease Risk Factors
Disease Classification & Coding
Approval & Labeling
Pricing Policy & Schemes
Reimbursement & Access Policy
Insurance Systems & National Health Care
Public Spending & National Health Expenditures
Coverage with Evidence Development & Adaptive Pathways
Health Disparities & Equity
Hospital and Clinical Practices
Pharmacist Interventions and Practices
Quality of Care Measurement
Disease Management (including optimization studies)
Treatment Patterns and Guidelines
Systems & Structure
Value Frameworks & Dossier Format
Decision & Deliberative Processes
Digital Health (includes HIT, mhealth, wearables)
Diagnostics & Imaging
Artificial Intelligence, Machine Learning, Predictive Analytics
Confounding, Selection Bias Correction, Causal Inference
Modeling & Simulation
PRO & Related Methods
Academic & Educational
Best Research Practices
Geographic & Regional (not for epidemiology or treatment evaluation studies of population subgroups)
Adherence, Persistence, & Compliance
Stated Preference & Patient Satisfaction
Health State Utilities
Patient-reported Outcomes & Quality of Life Outcomes
Patient Behavior and Incentives
Instrument Development, Validation, & Translation
Data Protection, Integrity, & Quality Assurance
Health & Insurance Records Systems
Distributed Data & Research Networks
Reproducibility & Replicability
Administrative Claims Data
Decision Modeling & Simulation
Electronic Medical & Health Records
Literature Review & Synthesis
Meta-analysis & Indirect Comparisons
Pragmatic Trials & Large Simple Trials
Prospective Observational Studies
Surveys & Expert Panels
STEP 4: PRIMARY SPECIFIC DISEASE & CONDITIONS/SPECIALIZED TREATMENT AREAS FOR CASE STUDY SUBMISSIONS
Accepted case study abstracts are grouped according to specific diseases/specialized treatment areas for panel presentations. Please indicate one specific diseases/specialized treatment areas below to assist in assigning your abstract for poster presentation. You can select "No Specific Disease" if these choices do not apply.
Please note you will have the opportunity to select additional specific diseases/specialized treatment areas to represent your research on the next submission step.
Cardiovascular Disorders (including MI, Stroke, Circulatory)
Diabetes/Endocrine/Metabolic Disorders (including obesity)
Infectious Disease (non-vaccine)
Injury & Trauma
Mental Health (including addition)
Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal)
Rare & Orphan Diseases
Reproductive & Sexual Health
Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)
Sensory System Disorders (Ear, Eye, Dental, Skin)
Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)
Biologics & Biosimilars
Genetic, Regenerative & Curative Therapies
Personalized & Precision Medicine
STEP 5: SPECIFIC DISEASE/SPECIALIZED TREATMENT AREAS FOR CASE STUDY SUBMISSIONS
In addition to your primary disease provided on the previous page, please select up to four additional disease & conditions/specialized treatment areas that best describe your abstract.
If you do not want to select any additional options, select "No Additional Disease & Conditions/Specialized Treatment Areas."
STEP 6: LOCATION
Select all geographic regions that apply to your case study abstract.
STEP 7: AUTHORS
Include all authors that are affiliated with your case study abstract. You will have to assign at least one Presenting Author upon submission. No more than 3 authors can be designated as a presenter. If multiple perspectives are being included, then coauthors/presenters representing each perspective are expected. Total case study presentation time will be 15-20 minutes, depending on the number of presenters. Please note: you will have the opportunity to update your presenting author(s) closer to the conference.
All accepted presenting authors must register for the meeting and are responsible for their meeting registration fees, unless otherwise notified in writing by ISPOR.
Submitters will receive confirmation of submission. It is the responsibility of the submitter to coordinate with authors after the submission status notification is received. ISPOR will communicate then with presenting authors directly regarding their abstract’s acceptance/rejection status and conference participation.
STEP 8: ABSTRACT TEXT
Copy and paste your abstract text from your preferred Word processor. Do not remove included headers (Problem Statement, Description, Lessons Learned, Stakeholder Perspective). Abstract has a 300 maximum word count. You can apply special formatting using the provided buttons along the top of the text box.
STEP 9: CONFIRMATION
Review your submission and complete the “Final Steps” acknowledgement form at the bottom. You must complete this final step and select “Conclude Submission,” otherwise your submission will be considered incomplete and not submitted for review. Please note: you will need to complete this step every time you update your submission.
CRITERIA FOR EVALUATION OF CASE STUDY ABSTRACTS:
Please consider the updated submission criteria when submitting your proposal:
Quality of content
- Educational value of the session
- Timeliness of the topic
- Applicability of content to HEOR practice or principles
- Unbiased content that does not promote a product, service, or organization; (abstracts deemed to be promotional will be excluded from consideration)
How well does the submission meet the topic it was submitted under?
Was there a lesson learned?
Are multiple stakeholders/organizations represented?
How well does the submission clearly identify the issue or problem being addressed?
How well does the submission exemplify the use of HEOR in healthcare decision-making?